Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 23, 2025

Costco: Buy It Again Before Everyone Else Catches On

View original at finance.yahoo.com
Costco: Buy It Again Before Everyone Else Catches On This article first appeared on GuruFocus. Costco (COST) is one of my favorite stocks to generally own, sometimes trade…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The trip to $500 billion market cap could play out over 12 to 24 months

    80% confidence
  • Costco's membership fees have historically grown at a pace surpassing 5% in most recent fiscal year

    80% confidence
  • Membership fee increases of around 10% occur every six or seven years

    80% confidence
  • Costco has potential to operate 520 stores in UK, Germany, Australia and Japan versus current 80

    80% confidence
  • Best-case scenario suggests opportunity for membership increase of 50% in four developed countries alone

    80% confidence
  • Fed's dot plot suggests three more rate cuts of 25 bps through end of next year

    80% confidence
  • Author assumes Costco's retail business at 2% operating margin is worth nothing to shareholders in valuation model

    80% confidence
  • Costco stock could prove countercyclical if market hits a pothole

    80% confidence
  • Costco has a membership renewal rate of more than 92%

    80% confidence
  • Costco has upside potential of 22% to $500 billion market cap, or even more in best-case scenario

    80% confidence
  • The best opportunity to buy Costco and earn strong double-digit returns is well behind us now

    80% confidence
  • A 10-bp reduction in risk-free rate would add roughly 10% to upside opportunity

    80% confidence
  • Costco remains misunderstood by too many potential investors despite efficient market premise

    80% confidence
  • Membership revenues carry very little direct costs and flow almost cleanly to pretax income

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Costco: Buy It Again Before Everyone Else Catches On — Source | Via News | ViaNews Market